PuraPharm
1498.HKPuraPharm Corporation Limited Price (1498.HK)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
395,052,941
(0.1186)%Revenue and Profitability
| Year | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 342,303,000 | 366,352,000 | 473,900,000 | 535,986,000 | 591,566,000 | 745,503,000 | 695,879,000 | 601,815,000 | 659,592,000 | 448,069,000 | 406,859,000 |
| Net Income | 26,264,000 | 34,463,000 | 28,458,000 | 32,162,000 | 1,889,000 | 20,806,000 | -227,258,000 | 31,710,000 | -121,877,000 | -120,214,000 | -106,081,000 |
| FCF USD | -6,153,000 | 22,505,000 | -40,985,000 | -97,112,000 | -144,380,000 | 27,269,000 | 4,976,000 | 3,836,000 | -45,886,000 | 42,290,000 | 57,947,000 |
| OCF USD | 11,034,000 | 31,091,000 | -12,570,000 | -55,828,000 | -42,752,000 | 72,461,000 | 101,935,000 | 86,682,000 | -39,327,000 | 65,848,000 | 79,608,000 |
Financial Health - DEBT
| Year | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YTPD | 0.00 | 0.00 | 0.00 | 0.00 | 28.73 | 7.90 | -0.82 | 6.73 | -0.91 | -0.62 | -0.97 |
| D/E | 2.58 | 1.35 | 0.27 | 0.57 | 1.00 | 0.98 | 1.50 | 1.02 | 1.32 | 1.95 | 2.77 |
| CA/CL | 0.89 | 1.08 | 2.40 | 1.64 | 1.01 | 1.22 | 0.94 | 1.03 | 0.92 | 0.73 | 0.61 |
| TA/TL | 1.27 | 1.48 | 3.06 | 2.12 | 1.74 | 1.73 | 1.42 | 1.60 | 1.50 | 1.34 | 1.22 |
| Total Debt | 188,190,000 | 182,692,000 | 125,431,000 | 261,048,000 | 548,021,000 | 548,477,000 | 541,533,000 | 524,111,000 | 531,958,999 | 503,157,000 | 424,770,000 |
Management Performance
| Year | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROIC | 12.65% | 14.05% | 5.99% | 5.08% | -0.05% | 0.72% | -6.86% | -0.35% | 1.91% | -8.34% | -11.51% |
| ROE | 35.96% | 25.40% | 6.06% | 7.08% | 0.34% | 3.70% | -62.76% | 6.20% | -30.35% | -46.54% | -69.23% |
| ROA | 0.00% | 8.20% | 4.08% | 3.74% | 0.15% | 1.56% | -18.59% | 2.31% | -10.11% | -11.83% | -12.57% |
| NM % | 7.67% | 9.41% | 6.01% | 6.00% | 0.32% | 2.79% | -32.66% | 5.27% | -18.48% | -26.83% | -26.07% |
| FCF / R% | 0.00% | 6.14% | -8.65% | -18.12% | -24.41% | 3.66% | 0.72% | 0.64% | -6.96% | 9.44% | 14.24% |
| FCF / NI% | -23.43% | 65.30% | -144.02% | -301.95% | -7,643.20% | 131.06% | -2.19% | 12.10% | 37.65% | -35.18% | -54.63% |
| Operating Margin (OM) | 0.00 | 0.28 | 0.27 | 0.30 | 0.28 | 0.25 | -0.10 | -0.06 | -0.24 | -0.63 | -0.88 |
Per Share
| Year | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | 0.00 | 74.54 | 0.15 | 0.14 | 0.01 | 0.08 | -0.82 | 0.09 | -0.31 | -0.30 | -0.27 |
| SPS | 0.00 | 792.33 | 2.42 | 2.40 | 2.47 | 3.02 | 2.52 | 1.62 | 1.68 | 1.14 | 1.03 |
| OCPS | 0.00 | 67.24 | -0.06 | -0.25 | -0.18 | 0.29 | 0.37 | 0.23 | -0.10 | 0.17 | 0.20 |
| FCPS | 0.00 | 48.67 | -0.21 | -0.43 | -0.60 | 0.11 | 0.02 | 0.01 | -0.12 | 0.11 | 0.15 |
| BVPS | 0.00 | 293.73 | 2.40 | 2.03 | 2.30 | 2.28 | 1.32 | 1.39 | 1.02 | 0.66 | 0.39 |
Per Share - CAGR
| Year | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CAGR-EPS | 0.00 | 74.54 | 0.15 | 0.14 | 0.01 | 0.08 | -0.82 | 0.09 | -0.31 | -0.30 | -0.27 |
| CAGR-SPS | 0.00 | 792.33 | 2.42 | 2.40 | 2.47 | 3.02 | 2.52 | 1.62 | 1.68 | 1.14 | 1.03 |
| CAGR-OCPS | 0.00 | 67.24 | -0.06 | -0.25 | -0.18 | 0.29 | 0.37 | 0.23 | -0.10 | 0.17 | 0.20 |
| CAGR-FCPS | 0.00 | 48.67 | -0.21 | -0.43 | -0.60 | 0.11 | 0.02 | 0.01 | -0.12 | 0.11 | 0.15 |
| CAGR-BVPS | 0.00 | 293.73 | 2.40 | 2.03 | 2.30 | 2.28 | 1.32 | 1.39 | 1.02 | 0.66 | 0.39 |